Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease

Thorax

Volumn 53, Issue 6, 1998, Pages 477-482

  Bourbeau, Jean ^a,c   Rouleau, Michel Y ^b   Boucher, Serge ^b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Chronic obstructive pulmonary disease; Drug therapy; Inhaled corticosteroids

Indexed keywords

BUDESONIDE; CORTICOSTEROID; PREDNISONE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0031749414     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.6.477     Document Type: Article

References (22)

1. Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis (see comments). Ann Intern Med 1991;114:216-23.
2. Shim CS, Williams Jr MH. Aerosol beclomethasone in patients with steroid-responsive chronic obstructive pulmonary disease. Am J Med 1985;78:655-8.
3. Bourbeau JR, Rouleau M, Boucher S, Krusky M. A double blind randomized study of inhaled budesonide in patients with steroid-responsive COPD. Am Rev Respir Dis 1993; 147:A317.
4. Robertson AS, Gove RI, Wieland GA, et al. A double-blind comparison of oral prednisolone 40 mg/day with inhaled beclomethasone dipropionate 1500 ug/day in patients with adult onset chronic obstructive airways disease. Eur J Respir Dis 1986;69:65-9.
5. Overbeek SE, Hilvering C, Bogaard JM, et al. A comparison of the efficacy of high dose and normal dose budesonide in prednisone dependent patients with chronic obstructive lung disease (COLD). Eur J Respir Dis 1986,69:581-4.
6. Wardman AG, Simpson FG, Knox AJ, et al. The use of high dose inhaled beclomethasone dipropionate as a means of assessing steroid responsiveness in obstructive airways disease. Br J Dis Chest 1988;82:168-71.
7. Hall TG, Kasik JE, Bedell GN, et al. The efficacy of inhaled beclomethasone in chronic obstructive airway disease. Pharmacotherapy 1989;9:232-9.
8. Weir DC, Burge PS. Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction. Thorax 1993;48:309-16.
9. Auffarth B, Postma DS, de Monchy JG, et al. Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease. Thorax 1991;46:372-7.
10. Kerstjens HA, Brand PL, Hughes MD et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. N Engl J Med 1993;327(20):1413-9.
11. Thompson AB, Mueller MB, Heires AJ, et al. Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation. Am Rev Respir Dis 1992;146:389-95.
12. Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-34.
13. Osterman JW, Armstrong BG, Ledoux E, et al. Comparison of French and English versions of the American Thoracic Society respiratory questionnaire in a bilingual working population. Int J Epidemiol 1991;20:138-43.
14. Butland RJA, Pang J, Gross ER, et al. Two-, six-, and twelve-minute walking tests in respiratory disease. BMJ 1982;284: 1607-8.
15. Guyatt GH, Pugsley SO, Sullivan MJ, et al. Effect of encouragement on walking test performance. Thorax 1984; 39:818-22.
16. Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987;42:773-8.
17. American Thoracic Society. Standardization of spirometry: 1987 update. Am Rev Respir Dis 1987;136:1285-98.
18. Lebowitz M, Quackenboss J, Camille A, et al. The epidemiological importance of intra-individual changes in objective pulmonary responses. Eur J Epidemiol 1990;132: 237-74.
19. SAS/STAT, SAS/STAT user's guide, version 6. 1st edition. Cary: SAS Institute, 1990.
20. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-15.
21. Lacasse Y, Guyatt GH, Goldstein RS. The components of a respiratory rehabilitation program: a systematic overview. Chest 1997;111:1077-88.
22. Van Andel AE, Reisner C, Menjoge SS, et al. Analysis of inhaled corticosteroids and oral theophylline use among COPD patients from 1987 to 1996. Am J Respir Crit Care Med 1997;155:A279.